A detailed history of Aquatic Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 227,900 shares of GILD stock, worth $15.6 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
227,900
Holding current value
$15.6 Million
% of portfolio
0.55%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $16.3 Million - $19.9 Million
227,900 New
227,900 $16.7 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $3.41 Million - $3.72 Million
46,100 New
46,100 $3.46 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $167,968 - $210,482
-2,900 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $188,152 - $213,556
2,900 New
2,900 $211,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $86B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.